| 刘晓怡,王珂,苟心怡,王屹,洪楠,程瑾.MRI基于2023版国际妇产科联盟分期评估子宫内膜癌进展[J].中国医学影像技术,2024,40(4):622~625 |
| MRI基于2023版国际妇产科联盟分期评估子宫内膜癌进展 |
| Progresses of MRI evaluating endometrial cancer based on 2023 International Federation of Gynecology and Obstetrics staging |
| 投稿时间：2023-12-07 修订日期：2023-12-26 |
| DOI：10.13929/j.issn.1003-3289.2024.04.031 |
| 中文关键词: 子宫内膜肿瘤 肿瘤分期 磁共振成像 |
| 英文关键词:endometrial neoplasms neoplasm staging magnetic resonance imaging |
| 基金项目: |
|
| 摘要点击次数: 892 |
| 全文下载次数: 643 |
| 中文摘要: |
| 子宫内膜癌(EC)是常见妇科恶性肿瘤;MRI对EC评估具有重要价值。2023年国际妇产科联盟(FIGO)分期做出重大修订,以更细致地对EC进行风险分层,也使MRI面临新的挑战。本文就MRI基于2023版FIGO分期评估EC进展进行综述。 |
| 英文摘要: |
| Endometrial cancer (EC) is a common gynecological malignancy. MRI plays an important role for evaluation of EC. In 2023, International Federation of Gynecology and Obstetrics (FIGO) staging was significantly modified to perform more detailed risk stratification of EC, which brought new challenges to MRI. The progresses of MRI for evaluating EC based on 2023 FIGO staging were reviewed in this article. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
